Senores Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Senores Pharmaceuticals has informed the stock exchanges that its trading window will be closed starting April 1, 2026, until 48 hours after the announcement of audited financial results for the quarter and financial year ending March 31, 2026. During this period, directors, promoters, designated persons, and their immediate relatives are prohibited from trading in the company's shares. The date of the board meeting to approve the audited results will be communicated separately. This is a standard compliance measure under SEBI's insider trading regulations ahead of results declaration.
This is a routine regulatory filing with no direct impact on shareholders. It signals that the company's Q4 and FY26 audited results announcement is upcoming, which may be a relevant event for investors to watch.